2 min read

OCT East Recap: RWD Trends in Clinical Studies

Research stakeholders met at this industry event to discuss trends in the clinical trial landscape.
This prominent clinical trial event discussed the future of real-world evidence and it's importance.

Pharmaceutical leaders and scientists converged at the recent Outsourcing in Clinical Trials East Conference in King of Prussia, Pennsylvania, to share ideas and discuss recent trends in the clinical trial landscape. One prominent topic continues to revolve around Real World Evidence and the trends emerging within RWE and RWD.

UBC’s Aaron Berger, Senior Director Safety Epidemiology Registries and Risk Management, presented on the essential role that Real World Data and Evidence can play in clinical trial design and execution. This presentation addressed several key concepts:

  • Regulator and payer communities have recognized the immense potential RWD brings to accelerating our ability to answer important questions about the safety and effectiveness of medical treatments.
  • Leveraging RWD is an essential consideration in the design and execution of clinical trials and registries.
  • There are practical applications and use cases for RWD in the domains of study design optimization, site and patient identification, and EMR/EDC interoperability.

UBC is a leading provider of evidence-generation capabilities and our unique expertise in “identifying the right evidence for the right purpose” sets us apart. Our expertise in evidence-generation supports the optimization of your approval pathway, product positioning, and safety profile maturation. By staying on top of RWE and RWD trends we are able to utilize fit-for-purpose technology that drives deep insight for sponsors.

To learn more about our practical applications of RWE and partnering in navigating the evidence-generation landscape, please contact us at contact@ubc.com to initiate the discussion on unlocking the value of RWD and RWE for your next clinical trial or registry.

Other Recent Posts

3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
3 min read

UBC Recognized as a Citeline Awards Finalist Again

The Citeline Awards have recognized UBC & Seqster’s innovative collaboration as a shortlisted finalist for the Best Patient-Facing Technology Initiative Category in 2023.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.